|
03 May 2019 |
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease
|
|
02 May 2019 |
First FDA-approved vaccine for the prevention of dengue disease in endemic regions
|
|
02 May 2019 |
AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091
|
|
19 Apr 2019 |
Vaxiion Therapeutics Initiates Phase 1 Clinical Trial of VAX014 for the Treatment of Non-Muscle Invasive Bladder Cancer in the United States
|
|
17 Apr 2019 |
Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate
|
|
17 Apr 2019 |
Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
|
|
13 Apr 2019 |
Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
|
|
05 Apr 2019 |
NIH begins first-in-human trial of a universal influenza vaccine candidate
|
|
04 Apr 2019 |
Inovio's Novel HPV Therapy INO-3106 Demonstrates Clinical Efficacy Against Rare Respiratory Tract Tumors in Pilot Clinical Study
|
|
03 Apr 2019 |
Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGE™ Significantly Outperforms Current Prediction Methods
|
|
02 Apr 2019 |
Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
|
|
02 Apr 2019 |
IO Biotech Presents Data on an Immunomodulatory CCL22-based Vaccine at the American Association for Cancer Research Annual Meeting 2019
|
|
02 Apr 2019 |
Vaccibody AS and Nektar Therapeutics Present New Preclinical Data from their Immuno-Oncology Collaboration at the American Association for Cancer Research (AACR) Annual Meeting 2019
|
|
01 Apr 2019 |
ADXS-PSA in Combination with KEYTRUDA® Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer
|
|
30 Mar 2019 |
Preliminary Data from Phase 1 Study Evaluating ADXS-NEO Suggest Rapid Immunogenicity and Clinical Activity
|
|
27 Mar 2019 |
IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate
|
|
25 Mar 2019 |
European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint
|
|
22 Mar 2019 |
Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001
|
|
20 Mar 2019 |
Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
|
|
20 Mar 2019 |
PDC*line Pharma enters into a licensing agreement with leading Korean pharmaceutical company LG Chem to develop PDC*lung cancer vaccine in Asia
|
|
20 Mar 2019 |
SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer
|
|
20 Mar 2019 |
Emergent BioSolutions Initiates Phase 3 Clinical Study to Evaluate AV7909 for Post-Exposure Prophylaxis of Anthrax
|
|
19 Mar 2019 |
Allergy Therapeutics announces top-line Phase III results from its B301 clinical trial
|
|
19 Mar 2019 |
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
|
|
19 Mar 2019 |
IMV and Centre de Recherche du CHU de Québec-Université Laval Collaboration Awarded a CQDM Grant to Develop First-in-Class Dual Target T Cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
|
